Search

everythinglearnresearchcommunity

for

Search:↓

Notopterygii rhizoma et radix (Qiang Huo) can effectively treat psoriasis by reducing skin symptoms and inflammation.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Urban air pollution worsens hair loss in alopecia areata by increasing immune response.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Recognizing and treating related skin conditions can improve atopic dermatitis management.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Stress causes hair loss by disrupting hair growth cycles, and combining medical and cosmetic treatments can help manage it.

Individual choice in treating alopecia areata greatly impacts quality of life.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Low-dose oral minoxidil is increasingly used by dermatologists in the UK and Ireland to treat various hair loss conditions.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

Epithelial elements in superficial angiomyxomas are non-neoplastic growths mimicking embryogenesis.

Axitinib treatment turned a man's grey hair back to black.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

Erlotinib can cause excessive eyelash growth.

Alopecia areata patients are more likely to develop systemic lupus erythematosus.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Human dermal stem/progenitor cells can divide and differentiate more than hair follicle dermal papilla cells.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.